Altimmune Inc (ALT)
8.67
+0.26
(+3.15%)
USD |
NASDAQ |
Nov 22, 11:23
Altimmune Total Return Level: 15.82 for Nov. 21, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 21, 2024 | 15.82 |
November 20, 2024 | 15.15 |
November 19, 2024 | 14.06 |
November 18, 2024 | 13.46 |
November 15, 2024 | 14.32 |
November 14, 2024 | 15.91 |
November 13, 2024 | 17.92 |
November 12, 2024 | 17.86 |
November 11, 2024 | 13.83 |
November 08, 2024 | 14.45 |
November 07, 2024 | 14.04 |
November 06, 2024 | 13.76 |
November 05, 2024 | 13.23 |
November 04, 2024 | 12.78 |
November 01, 2024 | 12.68 |
October 31, 2024 | 12.68 |
October 30, 2024 | 12.72 |
October 29, 2024 | 13.85 |
October 28, 2024 | 13.19 |
October 25, 2024 | 12.59 |
October 24, 2024 | 12.73 |
October 23, 2024 | 12.65 |
October 22, 2024 | 12.80 |
October 21, 2024 | 12.98 |
October 18, 2024 | 12.95 |
Date | Value |
---|---|
October 17, 2024 | 12.78 |
October 16, 2024 | 12.91 |
October 15, 2024 | 13.25 |
October 14, 2024 | 12.10 |
October 11, 2024 | 11.86 |
October 10, 2024 | 11.33 |
October 09, 2024 | 11.50 |
October 08, 2024 | 11.74 |
October 07, 2024 | 11.48 |
October 04, 2024 | 11.72 |
October 03, 2024 | 11.57 |
October 02, 2024 | 11.80 |
October 01, 2024 | 11.84 |
September 30, 2024 | 11.55 |
September 27, 2024 | 12.18 |
September 26, 2024 | 12.82 |
September 25, 2024 | 13.17 |
September 24, 2024 | 13.40 |
September 23, 2024 | 13.55 |
September 20, 2024 | 14.66 |
September 19, 2024 | 14.25 |
September 18, 2024 | 13.98 |
September 17, 2024 | 14.25 |
September 16, 2024 | 14.26 |
September 13, 2024 | 14.83 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.049
Minimum
Nov 22 2019
62.59
Maximum
Jul 20 2020
17.37
Average
16.74
Median
Total Return Level Benchmarks
Eli Lilly and Co | 2168.95 |
Viking Therapeutics Inc | 51.63 |
Amgen Inc | 412.05 |
Avid Bioservices Inc | 12.25 |
NovaBay Pharmaceuticals Inc | 0.7198 |